Large Language Models Utility for Rapid On-Site Evaluation in Interventional Pulmonology

Read full text
Authors: Maayan Flaschner, Mordechai Reuven Kramer, Alex Krolik, Evgeni Gershman, Anna Tovar, Dror Rosengarten, Shai Moshe Amor, Barak Pertzov, Moshe Heching, Osnat Shtraichman, Lev Freidkin
Cited by: 1
References: 21

Abstract

Background/Objectives: Rapid on-site evaluation (ROSE) is a valuable technique in interventional procedures to immediately assess the adequacy and quality of biopsy specimens at the time they are obtained. The integration of artificial intelligence (AI) into ROSE workflows has demonstrated diagnostic accuracy comparable to that of experienced cytologists. However, clinical implementation of AI-based ROSE models is limited by complex and expensive development. In contrast, the use of free or near-free global large language models (LLMs) offers a significant advantage, making diagnostic support more accessible. Assess the diagnostic accuracy of the LLMs ChatGPT and Gemini in evaluating cytological smears during interventional pulmonology procedures. Methods: Retrospective evaluation of the efficacy of LLMs for assessment of cytological smears obtained from adult patients who underwent interventional bronchoscopic and ultrasound-guided biopsies between 2020 and 2025. Images of ROSE-prepared samples were analyzed by ChatGPT-4o, ChatGPT-5, ChatGPT-5 “thinking”, and Gemini 2.5 models. Results: Forty-eight procedures in 47 patients (mean age 65 years) were analyzed; 79% of biopsies were malignant. Using the final histopathology report as reference, cytologists achieved balanced accuracy of 0.75 (Gwet’s AC1 = 0.53, sensitivity 0.71, specificity 0.78). ChatGPT-5 “thinking” showed high concordance (accuracy 0.65, Gwet’s AC1 = 0.81, sensitivity 1.00, specificity 0.30). Gemini reached an accuracy of 0.59 (Gwet’s AC1 = 0.76, sensitivity 0.97, specificity 0.20). Conclusions: To our knowledge, this study is the first to evaluate LLM-assisted ROSE in interventional pulmonology. The results suggest the potential feasibility of integrating this AI technology into the workflow within the pulmonary division. Larger prospective studies are needed to confirm effects on diagnostic yield.

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment AI in cancer detection Artificial Intelligence in Healthcare and Education

Publication details

Journal / source
Diagnostics
Publisher
MDPI AG
Volume
16
Issue
11
Pages
1658–1658
Publication date
28 May 2026
Language
EN